San Diego, CA and Bergen, Norway (PRWEB) May 12, 2014
NeuroQuant is the first FDA-cleared and CE-Mark pending software medical device for automatic segmentation and measurement of subcortical brain structures from a set of magnetic resonance images. This breakthrough solution provides neurologists and radiologists with objective evidence of neurodegeneration that can support their clinical impression.
“We are happy to be able to provide our neurology and radiology customers with NeuroQuant’s quantitative brain volume information,” said Fredrik Isdal, CEO of NNL. “The consistent and accurate data provided in NeuroQuant’s reports is a vital component in the assessment of neurodegenerative disease – such as Alzheimer’s, Epilepsy, TBI and Multiple Sclerosis.”
“Quantitative measurements of brain volume loss are essential elements that are currently missing in the diagnosis process of many brain disorders,” said Guri Stark, CEO of CorTechs Labs. “Working with the NNL team and their impressive imaging expertise will help us fulfill our mission to assist European physicians in effectively diagnosing and treating serious neurological disorders.”
To learn more about CorTechs Labs and NeuroQuant®, please visit http://www.cortechslabs.com.
To learn more about NNL, please visit http://www.nordicneurolab.com.
About CorTechs Labs, Inc.
CorTechs develops and markets cutting-edge brain imaging solutions used by neurologists and radiologists in hundreds of clinics and research centers around the world. CorTechs' flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared and CE Mark pending medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the only FDA cleared medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician's desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer's disease, epilepsy and traumatic brain injury.
About Nordic NeuroLab
With over a decade of experience, NordicNeuroLab (NNL) provides products and solutions that define the field of functional MR imaging. From state of the art post-processing and visualization software for BOLD, Diffusion/DTI, and Perfusion/DCE imaging to fMRI hardware for audio and visual stimulation, eye tracking, and patient response collection, NNL's products are used around the world by researchers and clinicians alike. Ultimately, we are dedicated to bringing the most advanced neuroimaging tools to market while making functional MRI programs easy to implement.
We understand the growing need for reliable and innovative tools in this evolving field. As a result, we closely collaborate with research and clinical teams from both academic and medical centers, MR system manufacturers, and third party vendors to develop and manufacture hardware and software solutions that meet the needs of very experienced centers while developing training programs to make fMRI easy to adopt for more novice users.